Dr Kobina Gumiye Mensah-brown, MD | |
200 1st St Sw, Rochester, MN 55905-0001 | |
(507) 284-2511 | |
Not Available |
Full Name | Dr Kobina Gumiye Mensah-brown |
---|---|
Gender | Male |
Speciality | Neurological Surgery |
Location | 200 1st St Sw, Rochester, Minnesota |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1497404834 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | 32577 (Minnesota) | Secondary |
207T00000X | Neurological Surgery | 74680 (Minnesota) | Primary |
Entity Name | Mayo Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922074434 PECOS PAC ID: 6507778255 Enrollment ID: O20031103000285 |
News Archive
PacificHealth Laboratories, Inc., a nutrition technology company, announced today that it has signed a consulting agreement with Signal Nutrition LLC, a research and development company headed by former PHLI CEO and founder Dr. Robert Portman. This agreement supports PHLI'S efforts in focusing on its core businesses to drive growth and profitability.
Nearly nine out of 10 nursing home physicians said that using their mobile devices to look up prescription drug information prevented at least one adverse drug event in the previous month, according to a University of Pittsburgh School of Medicine Department of Biomedical Informatics study published last week in the Journal of the American Medical Directors Association.
Patients whose acute myelogenous leukemia (AML) had relapsed or was resistant to chemotherapy and those who were deemed unable to tolerate chemotherapy experienced responses to the selective BCL-2 inhibitor venetoclax (Venclexta), with complete remissions in some, according to phase II clinical trial data.
Researchers have uncovered mutations in the phosphatase Wip1 that enable cancer cells to foil the tumor suppressor p53, according to a study in The Journal of Cell Biology. The results could provide a new target for the treatment of certain cancers.
A multi-center study from the University of Pittsburgh's Graduate School of Public Health suggests that women wishing to decrease their risk of pelvic inflammatory disease (PID) should ensure that their sexual partners use condoms consistently.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Kobina Gumiye Mensah-brown, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 | Dr Kobina Gumiye Mensah-brown, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 |
News Archive
PacificHealth Laboratories, Inc., a nutrition technology company, announced today that it has signed a consulting agreement with Signal Nutrition LLC, a research and development company headed by former PHLI CEO and founder Dr. Robert Portman. This agreement supports PHLI'S efforts in focusing on its core businesses to drive growth and profitability.
Nearly nine out of 10 nursing home physicians said that using their mobile devices to look up prescription drug information prevented at least one adverse drug event in the previous month, according to a University of Pittsburgh School of Medicine Department of Biomedical Informatics study published last week in the Journal of the American Medical Directors Association.
Patients whose acute myelogenous leukemia (AML) had relapsed or was resistant to chemotherapy and those who were deemed unable to tolerate chemotherapy experienced responses to the selective BCL-2 inhibitor venetoclax (Venclexta), with complete remissions in some, according to phase II clinical trial data.
Researchers have uncovered mutations in the phosphatase Wip1 that enable cancer cells to foil the tumor suppressor p53, according to a study in The Journal of Cell Biology. The results could provide a new target for the treatment of certain cancers.
A multi-center study from the University of Pittsburgh's Graduate School of Public Health suggests that women wishing to decrease their risk of pelvic inflammatory disease (PID) should ensure that their sexual partners use condoms consistently.
› Verified 8 days ago
Dr. Rahul Kumar, MD, PHD Neurological Surgery Medicare: May Accept Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Dr. Jennifer Lee Perez, MD, PHD Neurological Surgery Medicare: May Accept Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Fredric B Meyer, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Robert J Spinner, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Hirotaka Hasegawa, Neurological Surgery Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Noor Malik, MBBS Neurological Surgery Medicare: Medicare Enrolled Practice Location: 200 First Street Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Archis Ramkrishna Bhandarkar, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 |